Literature DB >> 17673472

Current status of the infrastructure and characteristics of radiation oncology in Korea.

Seung Jae Huh1.   

Abstract

BACKGROUND: An analysis of radiotherapy infrastructure in Korea was performed in 2006 to collect data on treatment devices, the work force and new patients for future development plans.
METHODS: The survey included radiotherapy centers, their major equipment and personnel. The centers were categorized into four levels: level 0 (stand-alone teletherapy units); level 1 (teletherapy, brachytherapy, treatment planning system, and at least the part-time service of a medical physicist); level 2 (level 1 plus individual customized radiotherapy block and full-time medical physicist); and level 3 [level 2 plus intensity-modulated radiation therapy (IMRT), intra-operative radiation therapy or stereotactic radiotherapy].
RESULTS: A total of 61 facilities delivered radiation therapy with 104 megavoltage devices, which included 96 linear accelerators, two cobalt 60 units, three Tomotherapy, two CyberKnife units and one proton accelerator. There were 28,789 new radiotherapy patients in 2004. Personnel included 132 radiation oncologists, 50 radiation oncology residents, 64 physicists, 130 nurses and 369 radiation therapy technologists. Thirty-two percent (20 facilities) used a CT-simulator, 66% (40) used a PET or PET-CT scanner, and 35% (22) had the capacity to implement IMRT. Centers were also divided into four levels: 41% were included in level 3, 31% in level 2, 25% in level 1 and 3% in level 0.
CONCLUSIONS: There is a shortage of human resources. The distribution of megavoltage units per million inhabitants over the country was inadequate; geographic disparities were noted. Furthermore, the necessity of quality assurance for recent high-technology radiation therapy is increasing.

Entities:  

Mesh:

Year:  2007        PMID: 17673472     DOI: 10.1093/jjco/hym073

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  6 in total

1.  Clinical characteristics of radiation oncology in Korea during past 10 years.

Authors:  Young Hoon Ji; Mi Sook Kim; Haijo Jung; Seong Yul Yoo; Chul Koo Cho
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

2.  Implications of Radiotherapy Utilization in Korea from 2010 to 2019.

Authors:  Jeongshim Lee; Woo Chul Kim; Won Sup Yoon; Chai Hong Rim
Journal:  J Korean Med Sci       Date:  2021-05-10       Impact factor: 2.153

3.  A Survey of Radiation Therapy Utilization in Korea from 2010 to 2016: Focusing on Use of Intensity-Modulated Radiation Therapy.

Authors:  Chai Hong Rim; Jeongshim Lee; Woo Chul Kim; DaeSik Yang; Won Sup Yoon; Woong Sub Koom; Chul Yong Kim
Journal:  J Korean Med Sci       Date:  2018-02-26       Impact factor: 2.153

4.  The Clinical Utilization of Radiation Therapy in Korea between 2011 and 2015.

Authors:  Young-Seok Seo; Mi-Sook Kim; Jin-Kyu Kang; Won-Il Jang; Hee Jin Kim; Chul Koo Cho; Hyung Jun Yoo; Eun Kyung Paik; Yu Jin Cha; Jae Sun Yoon
Journal:  Cancer Res Treat       Date:  2017-04-25       Impact factor: 4.679

5.  Clinical utilization of radiation therapy in Korea, 2016.

Authors:  Eunji Kim; Won Il Jang; Mi-Sook Kim; Eun Kyung Paik; Hee Jin Kim; Hyung Jun Yoo; Kwangmo Yang; Chul Koo Cho
Journal:  J Radiat Res       Date:  2020-03-23       Impact factor: 2.724

6.  Multi-institutional comparison of intensity modulated radiation therapy (IMRT) planning strategies and planning results for nasopharyngeal cancer.

Authors:  Sung Ho Park; Hee Chul Park; Suk Won Park; Do Hoon Oh; Youngmin Choi; Jeung Kee Kim; Yong Chan Ahn; Won Park; Hyun Sook Suh; Rena Lee; Hoonsik Bae
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.